The prevention of severe COVID-19 in the elderly



Early administration of plasma with high titers of antibody against SARS-CoV2 to infected seniors reduced progression to severe COVID-19 by 48%. Selecting plasma with IgG titers above a median of 1:3,200 increased protection to 73%. Read the full study right here.


0 comments